Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

TAKARA BIO INC to Receive Grant

Tuesday, 17 Sep 2013 02:00am EDT 

TAKARA BIO INC announced that it has entered into a contract service agreement with Japanese Ministry of Economy, Trade and Industry on September 12, 2013, and will receive a government subsidy to support two gene therapy projects for two kinds of gene modified T lymphocytes that developed by the Company (MAGE-A4 TCR modified T lymphocytes and HSV-TK modified T lymphocytes), for JPY 94,006,500 in total with a period from September 12, 2013 to March 31, 2014. 

Company Quote

12.0 +0.85%
1:00am EST